National Health Investors, Inc. carries a market capitalization of 3.41B, placing it among publicly traded companies globally. Its enterprise value stands at 5.01B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.41B |
| Enterprise Value | 5.01B |
National Health Investors, Inc. currently has 49.12M shares outstanding.
| Shares Outstanding | 49.12M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
National Health Investors, Inc. trades at a trailing price-to-earnings ratio of 21.93. The price-to-sales ratio is 8.46, and the price-to-book ratio stands at 2.38.
| PE Ratio | 21.93 |
| PS Ratio | 8.46 |
| PB Ratio | 2.38 |
| P/TBV Ratio | 2.38 |
| P/FCF Ratio | 14.76 |
| P/OCF Ratio | 14.71 |
On an enterprise value basis, National Health Investors, Inc. trades at an EV/EBITDA multiple of 17.44 and an EV/FCF ratio of 16.48. The EV/Sales ratio of 11.60 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 25.54 provides insight into valuation relative to core operating earnings.
| EV / Sales | 11.60 |
| EV / EBITDA | 17.44 |
| EV / EBIT | 25.54 |
| EV / FCF | 16.48 |
National Health Investors, Inc. maintains a current ratio of 0.72, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 80.43, indicating elevated leverage, while an interest coverage ratio of 5.16 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 0.72 |
| Quick Ratio | 0.63 |
| Debt / Equity | 80.43 |
| Debt / EBITDA | 4.45 |
| Interest Coverage | 5.16 |
National Health Investors, Inc. posts a return on equity of 10.93 and a return on invested capital of 7.13.
| Return on Equity (ROE) | 10.93 |
| Return on Assets (ROA) | 5.89 |
| Return on Invested Capital (ROIC) | 7.13 |
| Return on Capital Employed (ROCE) | 8.16 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, National Health Investors, Inc. has paid 732,000.00 in income taxes, reflecting an effective tax rate of 0.44.
| Income Tax | 732,000.00 |
| Effective Tax Rate | 0.44 |
National Health Investors, Inc.'s stock has declined approximately -10.1801% over the past 52 weeks. The 50-day moving average sits at 74.85, while the 200-day moving average is 78.36.
| Beta (5Y) | N/A |
| 52-Week Price Change | -10.1801% |
| 50-Day Moving Average | 74.85 |
| 200-Day Moving Average | 78.36 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, National Health Investors, Inc. generated 432.12M in revenue and converted that into 166.80M in net income, yielding earnings per share of 3.44. EBITDA reached 287.31M, while operating income came in at 196.20M.
| Revenue | 432.12M |
| Gross Profit | 421.39M |
| Operating Income | 196.20M |
| Pretax Income | 166.12M |
| Net Income | 166.80M |
| EBITDA | 287.31M |
| EBIT | 196.20M |
| Earnings Per Share (EPS) | 3.44 |
National Health Investors, Inc. holds 30.39M in cash and equivalents against 1.28B in total debt, resulting in a net debt position of 1.24B. Total book value stands at 1.57B, with working capital of -146.96M providing operational flexibility.
| Cash & Cash Equivalents | 30.39M |
| Total Debt | 1.28B |
| Net Debt | 1.24B |
| Equity (Book Value) | 1.57B |
| Book Value Per Share | 31.99 |
| Working Capital | -146.96M |
National Health Investors, Inc. produced 248.68M in operating cash flow over the past twelve months.
| Operating Cash Flow | 248.68M |
| Capital Expenditures | N/A |
| Free Cash Flow | 248.68M |
| FCF Per Share | 5.19 |
National Health Investors, Inc. operates with a gross margin of 97.52, reflecting its pricing power and cost economics. The operating margin of 45.40 and net profit margin of 38.60 provide insight into operational efficiency.
| Gross Margin | 97.52 |
| Operating Margin | 45.40 |
| Pretax Margin | 38.44 |
| Profit Margin | 38.60 |
| EBITDA Margin | 66.49 |
The company's payout ratio of 107.07 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 3.66 |
| Dividend Yield | N/A |
| Payout Ratio | 107.07 |
| Shareholder Yield | -2.00 |
| FCF Yield | 6.77 |
National Health Investors, Inc. posts an Altman Z-Score of 3.28, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.28 |